Theory Paper IIDrNB Cardiology – Theory Notes

CARDIAC PET SCAN: CLINICAL APPLICATIONS

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IINTRODUCTION AND TECHNICAL SUPERIORITY OVER SPECT

  • The Core Physical Principle: Positron Emission Tomography (PET) detects pairs of collinear 511 keV gamma annihilation photons emitted in opposite directions (180 degrees apart) when a positron emitted by a radionuclide collides with an electron in myocardial tissue (electronic coincidence detection).
  • Technical Advantages Over Single-Photon Emission Computed Tomography (SPECT):
    • Absolute Dynamic Quantification: Unlike SPECT (which shows only relative regional perfusion normalized to the hottest myocardial segment and can completely miss “balanced three-vessel or Left Main ischemia”), dynamic first-pass PET quantifies absolute Myocardial Blood Flow (MBF) in mL/min/g at rest and peak hyperemia.
    • Superior Spatial and Temporal Resolution: Spatial resolution of 4 to 5 mm (vs. 10 to 12 mm for conventional SPECT) with routine CT-based Attenuation Correction built into hybrid PET/CT scanners (eliminating diaphragmatic and breast soft-tissue attenuation artifacts).
    • Lower Patient Radiation Dose and Rapid Protocol: Short-lived perfusion radiotracers deliver low effective radiation doses (1 to 3 mSv vs. 6 to 10 mSv for Tc-99m SPECT) and allow complete rest-stress imaging in 30 to 45 minutes.

IIMYOCARDIAL PERFUSION IMAGING AND CORONARY MICROVASCULAR DYSFUNCTION (ANOCA / INOCA)

  • Cardiac Perfusion Radiotracers:
    • Rubidium-82 (82Rb): Potassium analog produced on-site from a commercial Strontium-82 / Rubidium-82 generator (replaced every 4 to 6 weeks; physical half-life = 75 to 76 seconds); requires pharmacological vasodilator stress (adenosine, regadenoson, or dipyridamole).
    • Nitrogen-13 Ammonia (13NH3): On-site cyclotron-produced tracer (half-life = 9.96 minutes) with higher first-pass myocardial extraction (~80%) and superior image resolution (due to short positron range).
    • Oxygen-15 Water (H215O): On-site cyclotron tracer (half-life = 2.0 minutes); 100% freely diffusible and metabolically inert (the gold standard for research MBF quantification).
    • Fluorine-18 Flurpiridaz (18F-Flurpiridaz — AURORA Phase III Trial / FDA Approved Sept 2024): Novel mitochondrial complex-I binding tracer with a 110-minute half-life (allowing regional cyclotron unit-dose distribution without an on-site cyclotron or generator), very high first-pass extraction (~94%) across all flow rates, shortest positron range (sharpest spatial resolution), and ability to perform treadmill exercise PET as well as pharmacological stress.
    • Quantitative Myocardial Flow Reserve (MFR / CFR):
    • Calculation: MFR = Peak Hyperemic Stress MBF (normal >2.0 to 3.0 mL/min/g) / Resting MBF (normal ~0.7 to 1.0 mL/min/g).
    • Diagnostic Cut-off: An MFR (CFR) less than 2.0 (and especially less than 1.5) is definitively abnormal—unmasking either balanced multivessel epicardial CAD or diffuse Coronary Microvascular Dysfunction (CMD / INOCA) when epicardial arteries are non-obstructive (ACC/AHA 2021 Chest Pain Guideline Class IIa). Conversely, a normal global MFR (>2.0) carries a very high negative predictive value for excluding high-risk Left Main/3-vessel CAD and predicts a <1% annual cardiac mortality (“warranty period”).
    • Landmark Evidence — The PACIFIC Trial (Danad et al., JAMA Cardiol 2017): Prospective head-to-head comparison of Coronary CTA, SPECT, and Quantitative 15O-Water PET against invasive Fractional Flow Reserve (FFR <=0.80) in 208 patients with suspected CAD; PET achieved the highest overall diagnostic accuracy (85 percent; AUC 0.90), significantly outperforming both SPECT (77 percent) and Coronary CTA (74 percent) on a per-patient and per-vessel basis.
Clinical Application PET Radiotracer(s) & Patient Preparation Pathognomonic Diagnostic Pattern Guideline Class & Key Evidence
Epicardial CAD & Microvascular Angina (INOCA) 82Rb, 13NH3, H215O, or 18F-Flurpiridaz (Rest + Vasodilator Stress) Regional stress perfusion defect (epicardial CAD) or globally reduced MFR / CFR < 2.0 (balanced 3VD or CMD) Class I / IIa (2021 ACC/AHA Chest Pain & 2024 ESC CCS); PACIFIC Trial
Myocardial Viability (Ischemic Cardiomyopathy) Perfusion (13NH3/82Rb) + Metabolic 18F-FDG after Oral Glucose Load + Insulin Clamp Perfusion-Metabolism Mismatch (low perfusion + preserved/high FDG) = Viable Hibernating Myocardium; Concordant Match = Non-Viable Scar Class IIa / IIb pre-revascularization; PARR-2 Trial
Cardiac Sarcoidosis (Active Inflammation) Resting Perfusion + 18F-FDG after 24-h High-Fat, Zero-Carb Diet + >12–18 h Fast (+ IV UFH) Focal or Focal-on-Diffuse 18F-FDG uptake with resting perfusion defect (active macrophage granulomas on dark background) Recommended (HRS 2014 / AHA 2024 / ESC 2023) for diagnosis & steroid titration
Prosthetic Valve Endocarditis (PVE) & CIED Infection 18F-FDG PET/CT (with low-carb/fasting myocardial suppression) Intense focal heterogeneous perivalvular, conduit, pocket, or lead 18F-FDG uptake Class I Major Criterion in 2023 ESC Endocarditis Guidelines

IIIMYOCARDIAL VIABILITY ASSESSMENT IN ISCHEMIC CARDIOMYOPATHY

  • Metabolic Principle (The “Glucose Switch” of Hibernating Myocardium): Under normal aerobic fasting conditions, healthy cardiomyocytes preferentially oxidize Free Fatty Acids (FFAs) (~70 to 80 percent of ATP production). Chronically hypoperfused, hibernating cardiomyocytes downregulate oxidative fatty acid metabolism, translocate GLUT-1 and GLUT-4 transporters to the sarcolemma, and switch obligately to anaerobic/aerobic glucose utilization (glycolysis) to survive.
  • Dietary Protocol for Viability PET (Opposite of Sarcoidosis Protocol): To stimulate maximal glucose uptake by all living myocytes, the patient is given an oral glucose load (25 to 50 g) with supplemental IV insulin (or hyperinsulinemic-euglycemic clamp) prior to injecting 18F-Fluorodeoxyglucose (18F-FDG).
  • Three Diagnostic Patterns (Combined Perfusion + 18F-FDG Viability Scan):
    • Normal: Normal resting perfusion and normal 18F-FDG uptake.
    • Perfusion-Metabolism Mismatch (Viable Hibernating Myocardium): Reduced resting perfusion paired with preserved or enhanced 18F-FDG uptake (the highest-sensitivity non-invasive marker for predicting regional functional recovery after CABG). (Note: Normal resting perfusion with reduced FDG can occur in stunned/reperfused myocardium or LBBB septal remodeling.)
    • Concordant Perfusion-Metabolism Match (Transmural Non-Viable Scar): Reduced resting perfusion paired with concordantly reduced/absent 18F-FDG uptake.
    • Landmark Trial — PARR-2 Trial (Beanlands et al., JACC 2007): Randomized patients with severe ischemic LV dysfunction (LVEF <=35%) to FDG-PET-assisted management versus standard care; while the overall primary intention-to-treat composite narrowly missed significance (p = 0.16 due to 25% clinician non-adherence to PET recommendations), in the prespecified subgroup where clinicians adhered to the PET viability recommendations and in high-experience centers (Ottawa-FIVE substudy), FDG-PET guidance significantly reduced composite cardiac death, MI, and hospital readmission (HR 0.62).

IVCARDIAC SARCOIDOSIS AND MYOCARDIAL INFLAMMATION

  • Strict Physiological Myocardial Suppression Protocol (Mandatory Exam Distinction from Viability PET): Because normal cardiomyocytes avidly take up glucose after a meal (which would turn the entire LV bright and obscure inflammatory lesions), Cardiac Sarcoidosis PET requires switching normal cardiomyocytes completely to Free Fatty Acid metabolism so normal myocardium appears “black/dark” while activated macrophages and CD4+ T-cells inside sarcoid granulomas (which rely exclusively on insulin-independent GLUT-1/GLUT-3 glycolysis) light up brightly:
  • Preparation: At least 2 meals (24 hours) of a high-fat (>35 g fat), high-protein, strictly zero-carbohydrate (<3 g carb) ketogenic diet, followed by a 12-to-18-hour fast, plus Intravenous Unfractionated Heparin (50 IU/kg IV bolus 15 minutes before 18F-FDG injection) (heparin activates lipoprotein lipase to flood plasma with free fatty acids).
  • Diagnostic Patterns (Paired Resting Perfusion + 18F-FDG Scan):
    • Normal: Normal perfusion and complete absence of myocardial 18F-FDG uptake.
    • Early Active Inflammation: Normal perfusion with focal 18F-FDG uptake.
    • Advanced Active Inflammation + Scar (“Mismatch”): Resting perfusion defect paired with intense focal or focal-on-diffuse 18F-FDG uptake (classically in the basal interventricular septum, lateral LV wall, and RV free wall, often accompanied by FDG-avid mediastinal/hilar lymph nodes).
    • Burnt-Out Fibrotic Scar: Resting perfusion defect with absent 18F-FDG uptake (indicates inactive scar; requires ICD evaluation rather than steroid escalation).

VINFECTIVE ENDOCARDITIS AND CIED INFECTION (ESC 2023 ENDOCARDITIS GUIDELINES)

  • Class I Major Diagnostic Criterion for Prosthetic Valve Endocarditis (PVE): In the 2023 ESC Guidelines for the Management of Endocarditis, abnormal intense focal or heterogeneous perivalvular 18F-FDG PET/CT uptake (or 99mTc-HMPAO-labeled WBC SPECT/CT) is a Class I (Level B) Major Imaging Criterion in the ESC Modified Duke Criteria for suspected Prosthetic Valve Endocarditis (PVE) when echocardiography is inconclusive (upgrading sensitivity from ~60% to >85–90%), and detects silent extracardiac septic emboli / mycotic aneurysms in 30 to 40 percent of patients. (Caution: Mild, homogeneous diffuse perivalvular uptake within 3 months of valve surgery or around BioGlue surgical adhesive can represent sterile postoperative inflammation and must be distinguished using qualitative pattern and quantitative SUV/spleen ratios.)
  • Cardiac Implantable Electronic Device (CIED) and LVAD Infections: High diagnostic accuracy (most useful for pocket infection, less sensitive for lead endocarditis) and for localizing vascular graft / aortic endograft and LVAD driveline/cannula infections.

VIPRACTICAL CONSIDERATIONS IN THE INDIAN CLINICAL CONTEXT

  • The “Tuberculosis vs. Cardiac Sarcoidosis” FDG-PET Trap: Both Mycobacterium tuberculosis (caseating granulomas) and Cardiac Sarcoidosis (non-caseating granulomas) produce identical intense focal myocardial and mediastinal lymph node 18F-FDG uptake on PET/CT. Starting empirical high-dose corticosteroids or infliximab based solely on a positive FDG-PET in an Indian patient without microbiological/histological exclusion of tuberculosis (EBUS-TBNA of FDG-avid mediastinal nodes for Xpert MTB/RIF Ultra, AFB, and MGIT culture, plus IGRA/Mantoux) can precipitate fatal disseminated tuberculosis.
  • Strict Carbohydrate Restriction Counseling in Vegetarian Indian Patients: Because traditional Indian vegetarian diets are heavily carbohydrate-based (rice, roti, dal, milk, fruits), many Indian patients inadvertently consume carbohydrates before a sarcoidosis PET scan, causing diffuse non-diagnostic LV FDG uptake; providing an explicit written Indian ketogenic menu (paneer, eggs/meat, butter/ghee, non-starchy green vegetables, and plain water) is mandatory.

Key references

  • Danad I, Raijmakers PG, Driessen RS, et al. (PACIFIC Investigators): Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve, JAMA Cardiology, 2017.
  • Beanlands RSB, Nichol G, Huszti E, et al. (PARR-2 Investigators): F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2), Journal of the American College of Cardiology, 2007.
  • Delgado V, Ajmone Marsan N, de Waha S, et al.: 2023 ESC Guidelines for the management of endocarditis, European Heart Journal, 2023.
  • Chareonthaitawee P, Beanlands RS, Chen W, et al.: Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid Detection and therapy monitoring, Journal of Nuclear Cardiology / Journal of the American College of Cardiology, 2017.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.